Aurobindo Pharma USA Inc. recalls Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc
Recalled February 23, 2022 · FDA recall D-0560-2022 · Aurobindo Pharma USA
Hazard
Failed Impurities/Degradation Specifications · FDA Class II
Units
115776 bottles
Sold at
USA Nationwide
Description
Failed Impurities/Degradation Specifications
Product
Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03
Manufacturer(s)
Aurobindo Pharma USA Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →